Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In re Curaleaf Holdings, Inc. Securities Litigation
Case Number:
1:19-cv-04486
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
February 16, 2021
Curaleaf Beats Investors' Stock-Drop Suit Over CBD Legality
A New York federal judge granted Curaleaf's bid Tuesday to toss a proposed securities class action alleging that the cannabis chain caused a drop in its share prices by improperly marketing CBD products, finding that Curaleaf properly disclosed the disputed information about the products' legality.
-
June 05, 2020
Investors Accuse Curaleaf Of Downplaying Stock Drop Claims
A proposed class of investors in cannabis company Curaleaf has asked a New York federal judge not to dismiss its claims alleging the company caused share prices to fall by improperly marketing CBD products, saying Curaleaf understated the severity of the claims.
-
March 09, 2020
Curaleaf Looks To Permanently End Investors' Stock-Drop Suit
Cannabis company Curaleaf is urging a New York federal court to permanently end a "weak" investor suit alleging Curaleaf caused share prices to fall by improperly marketing its CBD products as drugs, arguing that its securities filings disclosed the risks it's accused of hiding.
-
November 06, 2019
Wolf Haldenstein Tapped To Lead Curaleaf Stock Drop Suit
A New York federal judge on Wednesday named Wolf Haldenstein Adler Freeman & Herz LLP as lead counsel in a consolidated investor lawsuit against cannabis company Curaleaf, after several firms initially placed bids to lead the litigation.
-
October 21, 2019
Lead Counsel Field In Curaleaf Stock Suit Narrowed To 2
The lead counsel tussle in a proposed class action against cannabis giant Curaleaf Holdings Inc. has been winnowed down to two firms, with Levi & Korsinsky LLP and Wolf Haldenstein Adler Freeman & Herz LLP edging out four other competitors for the reins in a cannabidiol labeling stock drop case.
-
October 07, 2019
Pomerantz, Wolf Haldenstein Vie To Lead Curaleaf Stock Suit
Pomerantz LLP and Wolf Haldenstein Adler Freeman & Herz LLP are among half a dozen law firms that sought on Friday to lead a proposed consolidated class action against Curaleaf Holdings Inc. for allegedly causing share prices to fall by improperly marketing its CBD products as drugs.